Doctors from Scotland and the US have completed what is thought to be a world-first stroke procedure using a robot. BBC News ...

Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug ...

NEW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse cardiac ...

Caffeine appears to do the opposite of what you might think when it comes to the heart. Scientists have found that a cup of ...

Those who have undergone successful corrective procedures for irregular heart beats may no longer need to commit to long-term ...

A new study from researchers at Intermountain Health reveals that hypertensive disorders of pregnancy (HDP) significantly increase the risk of cardiovascular complications — including heart attack, ...

OCEAN, said Albert, provides important risk-benefit data that doctors can now use in discussions with their patients. For ...

The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease ...

OCEAN was an open-label trial conducted in Australia, Belgium, Canada, China, Germany, and Israel. Eligible participants had ...

The results have potential to change clinical practice.NEW ORLEANS — Left atrial appendage closure in patients with atrial ...

For some people with high cholesterol, making lifestyle changes and taking routine cholesterol-lowering statin medications may not be sufficient in helping them reach their target cholesterol levels.

In patients with atherosclerosis and/or diabetes without a prior heart attack or stroke, evolocumab cut the risk for first ...